Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders

Wolcott-Rallison syndrome

Wolcott-Rallison syndrome is an autosomal recessive disorder caused ba mutations of the EIF2AK3 gene. It ic characterized by early onset diabetes mellitus and multiple epiphyseal dysplasia.

Systematic

Permanent neonatal diabetes mellitus
ABCC8
Developmental delay, epilepsy, and neonatal diabetes
GCK
INS
KCNJ11
Phosphoribosylpyrophosphate synthetase superactivity
Wolcott-Rallison syndrome
EIF2AK3

References:

1.

Bin-Abbas B et. al. () Wolcott-Rallison syndrome: clinical, radiological and histological findings in a Saudi child.

[^]
2.

Durocher F et. al. (2006) A novel mutation in the EIF2AK3 gene with variable expressivity in two patients with Wolcott-Rallison syndrome.

[^]
3.

Brickwood S et. al. (2003) Wolcott-Rallison syndrome: pathogenic insights into neonatal diabetes from new mutation and expression studies of EIF2AK3.

[^]
4.

Bin-Abbas B et. al. (2002) Wolcott-Rallison syndrome in two siblings with isolated central hypothyroidism.

[^]
5.

Delépine M et. al. (2000) EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome.

[^]
6.

Bonthron DT et. al. (1998) Organisation of the human PAX4 gene and its exclusion as a candidate for the Wolcott-Rallison syndrome.

[^]
7.

Stewart FJ et. al. (1996) Wolcott-Rallison syndrome associated with congenital malformations and a mosaic deletion 15q 11-12.

[^]
8.

al-Gazali LI et. al. (1995) Wolcott-Rallison syndrome.

[^]
9.

Stöss H et. al. (1982) Wolcott-Rallison syndrome: diabetes mellitus and spondyloepiphyseal dysplasia.

[^]
10.

Wolcott CD et. al. (1972) Infancy-onset diabetes mellitus and multiple epiphyseal dysplasia.

[^]
Update: Sept. 26, 2018